Sonoma Pharmaceuticals (SNOA) Accounts Payables (2011 - 2026)
Sonoma Pharmaceuticals (SNOA) posted quarterly Accounts Payables of $2.3 million for Q1 2026, up 136.31% year-over-year from $953000.0 in Q1 2025, and up 36.82% quarter-over-quarter from $1.6 million in Q4 2025.
Sonoma Pharmaceuticals (SNOA) Accounts Payables (2011 - 2026) Analysis & Trends
Sonoma Pharmaceuticals' Accounts Payables history runs 16 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- In Q1 2026, Accounts Payables rose 136.31% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $2.3 million (up 136.31% YoY), while the FY2026 annual figure was $2.3 million, up 136.31% from the prior year.
- Accounts Payables for Q1 2026 stood at $2.3 million, up from $1.6 million in the prior quarter.
- The five-year high for Accounts Payables was $2.3 million in Q1 2026, with the low at $751000.0 in Q2 2024.
- The 5-year median for Accounts Payables is $1.8 million (2025), against an average of $1.7 million.
- The sharpest annual moves came in 2023 and 2025: Accounts Payables plunged 60.75% in 2023, then surged 144.47% in 2025.
- Sonoma Pharmaceuticals' Accounts Payables stood at $2.2 million in 2022, then slumped by 60.75% to $864000.0 in 2023, then soared by 121.76% to $1.9 million in 2024, then fell by 14.09% to $1.6 million in 2025, then jumped by 36.82% to $2.3 million in 2026.
- Business Quant data shows SNOA's Accounts Payables at $2.3 million in Q1 2026, $1.6 million in Q4 2025, and $1.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | Sonoma Pharmaceuticals | 5.17 Mn | -165,129.89 | 2.58 Mn | 2.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.67 Mn |
| Mar 31, 2026 | 2.25 Mn |
| Dec 31, 2025 | 1.65 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 1.84 Mn |
| Mar 31, 2025 | 953,000.00 |
| Dec 31, 2024 | 1.92 Mn |
| Sep 30, 2024 | 2.02 Mn |
| Jun 30, 2024 | 751,000.00 |
| Mar 31, 2024 | 2.11 Mn |
| Dec 31, 2023 | 864,000.00 |
| Sep 30, 2023 | 1.70 Mn |
| Jun 30, 2023 | 1.09 Mn |
| Mar 31, 2023 | 2.03 Mn |
| Dec 31, 2022 | 2.20 Mn |
| Sep 30, 2022 | 1.79 Mn |
| Jun 30, 2022 | 1.95 Mn |
| Mar 31, 2022 | 1.84 Mn |
| Dec 31, 2021 | 1.58 Mn |
| Sep 30, 2021 | 1.88 Mn |